Salarius Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Houston, Texas, United States • 11-20 Employees

Salarius Pharmaceuticals revenue & valuation

Annual revenue	$606,000
Revenue per employee	$47,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,000,000
Total funding	$6,000,000

Key Contacts at Salarius Pharmaceuticals

Tess Burleson

Member Board Of Directors, Chair Governance & Nominating Committee, Member Audit Committee

Mark J. Rosenblum

Chief Executive Officer & Cfo

Company overview

Headquarters	2450 Holcombe Blvd, Houston, Texas 77021, US
Phone number	+13467720346
Website	salariuspharma.com
NAICS	3254
SIC	873
Keywords	Cancer, Oncology, Epigenetics, Childhood Cancer, Solid Tumors
Founded	2011
Employees	11-20
Socials

Salarius Pharmaceuticals Email Formats

Salarius Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@salariuspharma.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@salariuspharma.com	100%

About Salarius Pharmaceuticals

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ product portfolio includes seclidemstat, a reversible LSD1 inhibitor, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule targeted protein degrader. Seclidemstat is currently in a Phase 1/2 clinical trial for relapsed/refractory Ewing sarcoma and select additional sarcomas that share a similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius is also exploring seclidemstat’s potential in several cancers with high unmet medical need, with a second Phase 1/2 clinical study in hematologic cancers, initiated by MD Anderson Cancer Center. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit salariuspharma.com or follow Salarius on Twitter and LinkedIn.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Senior

C-Suite

Director

Employees by Department

Salarius Pharmaceuticals has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Salarius Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-06-12	14	$6,000,000

Funding Insights

$6,000,000

Total funding amount

$6,000,000

Most recent funding amount

Number of funding rounds

Salarius Pharmaceuticals Tech Stack

Discover the technologies and tools that power Salarius Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Site Kit

Analytics

PWA

Miscellaneous

Google Maps

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

YouTube

Video players

Yoast SEO

SEO

Frequently asked questions

Salarius Pharmaceuticals is located in Houston, Texas, US.

You can reach Salarius Pharmaceuticals at +13467720346.

Salarius Pharmaceuticals generates an estimated annual revenue of $606,000. This revenue figure reflects the company's market position and business performance in its industry.

Salarius Pharmaceuticals has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Salarius Pharmaceuticals was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

Salarius Pharmaceuticals has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Salarius Pharmaceuticals has raised a total of $6,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Salarius Pharmaceuticals

Tess Burleson

Member Board Of Directors, Chair Governance & Nominating Committee, Member Audit Committee

Mark J. Rosenblum

Chief Executive Officer & Cfo

4.8

40,000 users